Full Text:  <320>

CLC number: 

On-line Access: 2024-12-30

Received: 2024-08-08

Revision Accepted: 2024-11-19

Crosschecked: 0000-00-00

Cited: 0

Clicked: 324

Citations:  Bibtex RefMan EndNote GB/T7714

-   Go to

Article info.
Open peer comments

Journal of Zhejiang University SCIENCE B

Accepted manuscript available online (unedited version)


Emerging role of the metabolite succinate in bone-related diseases


Author(s):  Zuping WU, Qiaoli DAI, Ying WANG, Na WU, Chenyu WANG, Jiejun SHI

Affiliation(s):  Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Clinical Research Center for Oral Diseases of Zhejiang Province, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou 310016

Corresponding email(s):  sjiejun@zju.edu.cn

Key Words:  Succinate; Osteoarthritis; Rheumatoid arthritis; Osteoporosis; Periodontitis


Share this article to: More <<< Previous Paper|Next Paper >>>

Zuping WU, Qiaoli DAI, Ying WANG, Na WU, Chenyu WANG, Jiejun SHI. Emerging role of the metabolite succinate in bone-related diseases[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B2400406

@article{title="Emerging role of the metabolite succinate in bone-related diseases",
author="Zuping WU, Qiaoli DAI, Ying WANG, Na WU, Chenyu WANG, Jiejun SHI",
journal="Journal of Zhejiang University Science B",
year="in press",
publisher="Zhejiang University Press & Springer",
doi="https://doi.org/10.1631/jzus.B2400406"
}

%0 Journal Article
%T Emerging role of the metabolite succinate in bone-related diseases
%A Zuping WU
%A Qiaoli DAI
%A Ying WANG
%A Na WU
%A Chenyu WANG
%A Jiejun SHI
%J Journal of Zhejiang University SCIENCE B
%P
%@ 1673-1581
%D in press
%I Zhejiang University Press & Springer
doi="https://doi.org/10.1631/jzus.B2400406"

TY - JOUR
T1 - Emerging role of the metabolite succinate in bone-related diseases
A1 - Zuping WU
A1 - Qiaoli DAI
A1 - Ying WANG
A1 - Na WU
A1 - Chenyu WANG
A1 - Jiejun SHI
J0 - Journal of Zhejiang University Science B
SP -
EP -
%@ 1673-1581
Y1 - in press
PB - Zhejiang University Press & Springer
ER -
doi="https://doi.org/10.1631/jzus.B2400406"


Abstract: 
Bone-related diseases, including osteoporosis (OP), osteoarthritis (OA), rheumatoid arthritis (RA), fractures, and periodontitis, significantly impact human health. Succinate, primarily known as a metabolic intermediate in the tricarboxylic acid (TCA) cycle, has emerged as a regulator of cellular functions beyond its metabolic role. Under stress, succinate accumulates in mitochondria and acts as a signaling molecule, modulating cellular processes. Notably, succinate activates angiogenesis and inflammation by stabilizing hypoxia-inducible factor 1 alpha (HIF-1α). Moreover, it influences various pathophysiological processes by interacting with the succinate receptor (SUCNR-1), thereby impacting immune response, inflammation, cancer metastasis, and bone homeostasis. The multifaceted roles of succinate as a signaling molecule vary depending on its cellular location and concentration. Recent metabolomic analyses have revealed elevated succinate levels in bone-related diseases, indicating its potential association with these conditions. The objective of this review is to elucidate the impact of succinate on different bone-related diseases and to discuss potential therapeutic targets and drug molecules based on its mechanisms of action.

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

Reference

Open peer comments: Debate/Discuss/Question/Opinion

<1>

Please provide your name, email address and a comment





Journal of Zhejiang University-SCIENCE, 38 Zheda Road, Hangzhou 310027, China
Tel: +86-571-87952783; E-mail: cjzhang@zju.edu.cn
Copyright © 2000 - 2025 Journal of Zhejiang University-SCIENCE